ResearchWVE
WVE: FY25 Deep Dive
Published 1 min read
Wave Life Sciences FY25 at $43M. NI $-204M; EPS $-1.21. Biotech — RNA.
WVE: FY25 Deep Dive
FY25 revenue $43M; OI $-215M; NI $-204M; EPS $-1.21.
Wave Life Sciences FY25 (Dec 31, 2025) at $43M revenue. OpInc $-215M; NI $-204M; EPS $-1.21. Biotech — RNA.
